Navigation Links
Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
Date:12/26/2007

SEATTLE, Dec. 26 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) management to hold a conference call tomorrow (Thursday, December 27) at 8:30 am EST to discuss update on Zevalin asset purchase, CMS reimbursement, and PIX301 timing for results.

Conference Call Numbers

Thursday, December 27

8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific

800-218-0204

303-262-2130

Webcast available at

http://www.cticseattle.com -

webcast will be archived approximately two hours after call ends.

Call-back numbers for post listening available at 10:00 am Eastern

800-405-2236

303-590-3000

Passcode: 11105647

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Susan Callahan

T: 206.272.4472

F: 206.272.4434

E: media@ctiseattle.com

http://www.cticseattle.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.cticseattle.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the fastest growing technologies in the life sciences industry. ... is driving growth in nucleic acid detection technologies like ... gene expressions will continue to benefit the qPCR and ... ranging from pharma, biotech, food & beverage to animal ...
(Date:3/3/2015)... - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a ... target the underlying mechanisms of cancer, today reported financial ... 31, 2014. Effective July 17, 2014, the ... to December 31. As a result of that change, ... quarter and the seven months ended December 31, 2014, ...
(Date:3/3/2015)... , March 3, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... million.  The orders are for odour control projects in ... and Asia . "Bidding activity in ... President and CEO. "After a high volume year for bidding in ... the New Year.  The recent orders reflect the organization,s renewed focus ...
(Date:3/3/2015)... , March 3, 2015 Adaptive Biotechnologies ... CFO, is joining its Board of Director as Chair ... officer at Zillow Group, Chad oversees all finance, treasury ... built the company,s core finance, treasury and accounting functions, ... and nine acquisitions. In 2013, he was named Puget ...
Breaking Biology Technology:Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2
... Sunlight represents the cleanest, greenest and far and away ... potential remains woefully under-utilized. High costs have been a ... cells. Nanopillars - densely packed nanoscale arrays of optically ... next generation of relatively cheap and scalable solar cells, ...
... DNDN ) today announced the Medicare Evidence ... of labeled and unlabeled use of PROVENGE® (sipuleucel-T) treatment ... This panel was convened as a part of the ... Centers for Medicare and Medicaid Services (CMS).   ...
... Nov. 17, 2010 Reportlinker.com announces that a ... catalogue: Global Anticoagulants Industry ... report analyzes the worldwide markets for Anticoagulants in ... Anticoagulants, and Injectable Anticoagulants (Unfractionated Heparin, & Low ...
Cached Biology Technology:A new twist for nanopillar light collectors 2A new twist for nanopillar light collectors 3Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence 2Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence 3Reportlinker Adds Global Anticoagulants Industry 2Reportlinker Adds Global Anticoagulants Industry 3Reportlinker Adds Global Anticoagulants Industry 4Reportlinker Adds Global Anticoagulants Industry 5Reportlinker Adds Global Anticoagulants Industry 6Reportlinker Adds Global Anticoagulants Industry 7Reportlinker Adds Global Anticoagulants Industry 8Reportlinker Adds Global Anticoagulants Industry 9Reportlinker Adds Global Anticoagulants Industry 10Reportlinker Adds Global Anticoagulants Industry 11Reportlinker Adds Global Anticoagulants Industry 12Reportlinker Adds Global Anticoagulants Industry 13Reportlinker Adds Global Anticoagulants Industry 14Reportlinker Adds Global Anticoagulants Industry 15Reportlinker Adds Global Anticoagulants Industry 16Reportlinker Adds Global Anticoagulants Industry 17
(Date:2/5/2015)... 28, 2015 Research and Markets ... the "Global Biometrics Market (2014-2020): Market Forecast ... report to their offering. , ... is anticipated to overtake ... increasing government spending towards IT security, government biometric ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
Breaking Biology News(10 mins):Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Scientists from the International Vaccine Institute (IVI) have discovered ... commonly referred to as matrix protein 2 (M2), when ... infection caused by various influenza viruses, including the highly ... flu") virus. Importantly, this experimental sublingual vaccine ...
... New Rochelle, NY, December 8, 2011 -- Fecal contamination of ... swimmers and costly for state and local economies. Current methods ... of the presence of fecal matter in water, typically require ... economical sensor-based device capable of measuring E. coli levels in ...
... Dec. 8, 2011 Reportlinker.com announces that ... in its catalogue: Global ... This report analyzes the ... US$ by the following Technologies: AFIS (Automated ...
Cached Biology News:Promising results in mice on needle-free candidate universal vaccine against various flu viruses 2Keeping our beaches safe 2Global Biometrics Industry 2Global Biometrics Industry 3Global Biometrics Industry 4Global Biometrics Industry 5Global Biometrics Industry 6Global Biometrics Industry 7Global Biometrics Industry 8Global Biometrics Industry 9Global Biometrics Industry 10Global Biometrics Industry 11Global Biometrics Industry 12Global Biometrics Industry 13Global Biometrics Industry 14Global Biometrics Industry 15Global Biometrics Industry 16Global Biometrics Industry 17Global Biometrics Industry 18Global Biometrics Industry 19Global Biometrics Industry 20Global Biometrics Industry 21Global Biometrics Industry 22Global Biometrics Industry 23Global Biometrics Industry 24
... are rigid macroporous hydrophilic media. The rigid ... moderate pressures, while the macroporous beads enhance ... matrix reduces nonspecific binding. Macro-Prep High Q ... with very high flow rates and resolution. ...
... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112...
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Biology Products: